肾结石患者补充钙和维生素D的管理

T. Soleymanian
{"title":"肾结石患者补充钙和维生素D的管理","authors":"T. Soleymanian","doi":"10.15171/JPD.2018.23","DOIUrl":null,"url":null,"abstract":"Nephrolithiasis is a common medical issue worldwide and it has an overall prevalence of 7% in women and 10.5% in men (1). It mainly affects active working age population and has high socioeconomic burden (2). Calcium comprises about 80%-90% of the kidney stones components as calcium oxalate and calcium phosphate, so that applying measures for reducing urine calcium excretion have increasingly been used (3). Calcium is absorbed by both active calcitriol-dependent and passive mechanisms in small bowel depending on the amount of daily consumption, and it ranges between 10% to 70% (4,5). It has been shown that kidney stone formers have higher fractional absorption of calcium in intestine leading to greater urinary calcium excretion (6,7). Multiple large studies have shown that calcium intake has a protective role against kidney stone formation by decreasing absorption of intestinal oxalate and subsequent decline in urine oxalate (8-10). Furthermore, Restriction of calcium intake not only would raise risk of oxalate absorption, it also has detrimental effect on bone mineral density which has already been lost in kidney stone formers (11). Therefore, moderate calcium intake of 800-1200 mg daily, mainly by calcium-rich diet or as supplementation taking with diet, is advocated for stone formers (12). It has been demonstrated that intake of calcium supplements both with and without meal increases urine calcium, but because of binding of dietary oxalate with calcium when it is taken with meal, the amount of intestinal oxalate absorption and its urine secretion declines and the rate of stone formation would not increase (13). Of note, apart from calcium intake in high amounts, several other dietary habits including low fluid intake, small intake of fruits and vegetable, large sodium intake, excessive consumption of diet rich in oxalate, and high meat intake are involved in stone formation (14). Therefore, patients who are taking calcium and vitamin D supplements should be advised to consider the foregoing predisposing factors of stone formation. Also, as several systemic diseases such as diabetes, obesity and hypertension are linked with stone disease (15,16), approaches for managing these conditions Implication for health policy/practice/research/medical education Taking recommended doses of supplemental calcium and vitamin D among nephrolithiasis patients have no significant consequence on kidney stone formation.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"38 1","pages":"74-75"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Administration of calcium and vitamin D supplementation in kidney stone formers\",\"authors\":\"T. Soleymanian\",\"doi\":\"10.15171/JPD.2018.23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nephrolithiasis is a common medical issue worldwide and it has an overall prevalence of 7% in women and 10.5% in men (1). It mainly affects active working age population and has high socioeconomic burden (2). Calcium comprises about 80%-90% of the kidney stones components as calcium oxalate and calcium phosphate, so that applying measures for reducing urine calcium excretion have increasingly been used (3). Calcium is absorbed by both active calcitriol-dependent and passive mechanisms in small bowel depending on the amount of daily consumption, and it ranges between 10% to 70% (4,5). It has been shown that kidney stone formers have higher fractional absorption of calcium in intestine leading to greater urinary calcium excretion (6,7). Multiple large studies have shown that calcium intake has a protective role against kidney stone formation by decreasing absorption of intestinal oxalate and subsequent decline in urine oxalate (8-10). Furthermore, Restriction of calcium intake not only would raise risk of oxalate absorption, it also has detrimental effect on bone mineral density which has already been lost in kidney stone formers (11). Therefore, moderate calcium intake of 800-1200 mg daily, mainly by calcium-rich diet or as supplementation taking with diet, is advocated for stone formers (12). It has been demonstrated that intake of calcium supplements both with and without meal increases urine calcium, but because of binding of dietary oxalate with calcium when it is taken with meal, the amount of intestinal oxalate absorption and its urine secretion declines and the rate of stone formation would not increase (13). Of note, apart from calcium intake in high amounts, several other dietary habits including low fluid intake, small intake of fruits and vegetable, large sodium intake, excessive consumption of diet rich in oxalate, and high meat intake are involved in stone formation (14). Therefore, patients who are taking calcium and vitamin D supplements should be advised to consider the foregoing predisposing factors of stone formation. Also, as several systemic diseases such as diabetes, obesity and hypertension are linked with stone disease (15,16), approaches for managing these conditions Implication for health policy/practice/research/medical education Taking recommended doses of supplemental calcium and vitamin D among nephrolithiasis patients have no significant consequence on kidney stone formation.\",\"PeriodicalId\":16657,\"journal\":{\"name\":\"Journal of Parathyroid Disease\",\"volume\":\"38 1\",\"pages\":\"74-75\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Parathyroid Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15171/JPD.2018.23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15171/JPD.2018.23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肾结石是世界范围内一种常见的医学问题,其总体患病率为女性7%,男性10.5%(1)。肾结石主要影响活跃的工作年龄人群,具有较高的社会经济负担(2)。钙以草酸钙和磷酸钙的形式占肾结石成分的80%-90%。因此,减少尿钙排泄的措施已被越来越多地使用(3)。钙在小肠中根据每日摄入量的不同,通过主动依赖骨化三醇的机制和被动机制被吸收,其范围在10%至70%之间(4,5)。有研究表明,肾结石患者在肠道中钙的吸收分数较高,导致尿钙排泄量增加(6,7)。多项大型研究表明,钙摄入通过减少肠道草酸盐的吸收和随后尿液草酸盐的下降,对肾结石的形成具有保护作用(8-10)。此外,限制钙的摄入不仅会增加草酸盐吸收的风险,还会对肾结石患者已经丢失的骨矿物质密度产生不利影响(11)。因此,对于结石患者,建议每日摄入800- 1200mg的钙,主要通过富含钙的饮食或在饮食中补充钙(12)。研究表明,无论是否膳食,摄入钙补充剂都会增加尿钙,但由于膳食中的草酸盐与钙结合,当膳食中摄入草酸盐时,肠道草酸盐的吸收率和尿液分泌量都会下降,结石形成的速度也不会增加(13)。值得注意的是,除了大量摄入钙外,其他几种饮食习惯,包括低液体摄入、少摄入水果和蔬菜、大量摄入钠、过量摄入富含草酸盐的饮食和大量摄入肉类,都与结石的形成有关(14)。因此,应建议服用钙和维生素D补充剂的患者考虑上述结石形成的易感因素。此外,由于一些全身性疾病,如糖尿病、肥胖和高血压与结石疾病有关(15,16),管理这些疾病的方法对卫生政策/实践/研究/医学教育的意义肾结石患者服用推荐剂量的补充钙和维生素D对肾结石的形成没有显著影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Administration of calcium and vitamin D supplementation in kidney stone formers
Nephrolithiasis is a common medical issue worldwide and it has an overall prevalence of 7% in women and 10.5% in men (1). It mainly affects active working age population and has high socioeconomic burden (2). Calcium comprises about 80%-90% of the kidney stones components as calcium oxalate and calcium phosphate, so that applying measures for reducing urine calcium excretion have increasingly been used (3). Calcium is absorbed by both active calcitriol-dependent and passive mechanisms in small bowel depending on the amount of daily consumption, and it ranges between 10% to 70% (4,5). It has been shown that kidney stone formers have higher fractional absorption of calcium in intestine leading to greater urinary calcium excretion (6,7). Multiple large studies have shown that calcium intake has a protective role against kidney stone formation by decreasing absorption of intestinal oxalate and subsequent decline in urine oxalate (8-10). Furthermore, Restriction of calcium intake not only would raise risk of oxalate absorption, it also has detrimental effect on bone mineral density which has already been lost in kidney stone formers (11). Therefore, moderate calcium intake of 800-1200 mg daily, mainly by calcium-rich diet or as supplementation taking with diet, is advocated for stone formers (12). It has been demonstrated that intake of calcium supplements both with and without meal increases urine calcium, but because of binding of dietary oxalate with calcium when it is taken with meal, the amount of intestinal oxalate absorption and its urine secretion declines and the rate of stone formation would not increase (13). Of note, apart from calcium intake in high amounts, several other dietary habits including low fluid intake, small intake of fruits and vegetable, large sodium intake, excessive consumption of diet rich in oxalate, and high meat intake are involved in stone formation (14). Therefore, patients who are taking calcium and vitamin D supplements should be advised to consider the foregoing predisposing factors of stone formation. Also, as several systemic diseases such as diabetes, obesity and hypertension are linked with stone disease (15,16), approaches for managing these conditions Implication for health policy/practice/research/medical education Taking recommended doses of supplemental calcium and vitamin D among nephrolithiasis patients have no significant consequence on kidney stone formation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Parathyroid crisis; a short look at an uncommon disease Types of application of artificial intelligence in the diagnosis and prognosis of osteoporosis; a narrative review Recent advancements in the treatment of tertiary hyperparathyroidism Vitamin D status in hemodialysis; current opinions Relationship of calcium-sensing receptor gene polymorphism CASR rs 1042636, CASR rs 1802757, and cinacalcet response among Egyptian hemodialysis patients with secondary hyperparathyroidism
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1